Clinical trial
Safety Study of AMG 531 in Japanese Subjects With ITP
NCT00305435 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00305435 |
|---|---|
| Title | Safety Study of AMG 531 in Japanese Subjects With ITP |
| Official title | An Open Label Phase 2 Study Evaluating the Safety of Starting Dose of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) |
| Intervention type | Drug |
| Interventions | Romiplostim (AMG-531) |
| Enrollment | 12 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Mar 22, 2006 |
| Last update posted | Jul 5, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: